| CA15-3 | Cancer Antigen 15-3 |
| CTC | Circulating Tumor Cell |
| DEAC | Development, Evaluation and Application Chart |
| PFS | Progression Free Survival |
| HER2 | Human Epidermal Growth Factor Receptor 2 |
| OS | Overall Survival |
| VEGF | Vascular Endothelial Growth Factor |
| VEGFR | Vascular Endothelial Growth Factor Receptor |